Liver transplants are one of the most successful major organ transplants performed today. About 93% of adult recipients of deceased donor livers survive the first year, and roughly 80% are alive five years later. For living donor transplants, the numbers are even better. These outcomes have improved dramatically over the past three decades, and most recipients report excellent quality of life after recovery.
Overall Survival Rates
The Scientific Registry of Transplant Recipients, which tracks every organ transplant in the United States, reports that adult deceased donor liver recipients have a mortality rate of about 5% at six months, 7% at one year, 20% at five years, and 36% at ten years. Flipped around, that means roughly 93% of recipients are alive at one year, 80% at five years, and 64% at ten years.
Living donor transplants perform even better across the board. A study of 486 liver transplant cases found that living donor recipients had survival rates of 93% at one year, 82% at five years, and 73% at ten years, compared to 88%, 73%, and 62% for deceased donor recipients. The transplanted organ itself (called the graft) also lasted longer in living donor cases. This difference likely reflects the shorter time between organ retrieval and surgery, along with the ability to plan the procedure in advance rather than operating on an emergency basis.
What Happens in the First Month
The surgery itself carries real risk. In one study of 103 liver transplant recipients, seven died during their initial hospital stay, putting the in-hospital mortality rate at about 7%. Six of those seven deaths occurred within the first 30 days, and infection was the cause in nearly all of them. The early post-transplant period is the most vulnerable window because the immune system is heavily suppressed to prevent the body from attacking the new organ, which leaves patients susceptible to bacterial and fungal infections.
Once past the first month, the risk of death drops significantly. Most of the long-term mortality in transplant statistics comes from gradual complications over years, not sudden surgical failure.
Rejection Is Common but Treatable
Your immune system will recognize the new liver as foreign tissue and try to attack it. This is called acute cellular rejection, and it happens more often than most people expect. In a large study of nearly 600 liver transplant recipients, about 38% to 46% experienced at least one episode of rejection that needed treatment, depending on whether they received a living or deceased donor organ. When confirmed by biopsy, about 27% of recipients in both groups had at least one proven rejection episode.
The good news is that acute rejection of a transplanted liver is usually reversible. It’s typically caught early through routine blood work and treated by adjusting your immunosuppressive medications. Rejection doesn’t mean the transplant has failed. It means the medication regimen needs fine-tuning, which is a normal part of the process for many recipients.
Success Depends on Why You Needed the Transplant
Not all liver transplants carry the same odds. The underlying condition that damaged your original liver plays a significant role in long-term outcomes.
For people transplanted because of liver cancer (hepatocellular carcinoma, or HCC), the main concern is tumor recurrence. Even with strict selection criteria for who qualifies, 10% to 20% of recipients who had HCC in their diseased liver will see the cancer return after transplantation. Studies using various selection criteria report five-year survival rates between 71% and 83% for HCC patients, which is somewhat lower than transplant recipients without cancer. The risk of recurrence drops considerably when tumors are small and haven’t invaded nearby blood vessels.
Transplants for conditions like alcohol-related liver disease and fatty liver disease (NASH/MASH) generally have strong outcomes, though long-term success depends heavily on managing the original risk factors. For alcohol-related disease, that means sustained sobriety. For fatty liver disease, it means controlling weight, diabetes, and metabolic health to protect the new organ from developing the same damage.
How Long a Transplanted Liver Lasts
A transplanted liver is not permanent, but it can last a very long time. In a landmark study of 4,000 consecutive patients at a single center, overall graft survival rates were 70% at one year, 59% at five years, 49% at ten years, 44% at fifteen years, and 41% at eighteen years. These numbers include both patient deaths and cases where a second transplant was needed, so they represent the proportion of original grafts still functioning in living patients.
Modern grafts are expected to perform better than these historical averages because surgical techniques, organ preservation, and post-transplant care have all improved. For the healthiest recipients with well-matched organs, a transplanted liver can function for 20 years or more.
Outcomes for Children
Pediatric liver transplants have seen the most dramatic improvement of any age group. Children transplanted between 2007 and 2018 had five-year patient survival of 91% and ten-year survival of 88%, compared to just 74% and 70% for children transplanted in the late 1980s and early 1990s.
Projected long-term data for the most recent era are striking. Children transplanted after 2007 are expected to have 84% survival at 20 years and 80% at 30 years. Graft survival projections are 75% at 20 years and 69% at 30 years, meaning most children will live well into adulthood with their original transplanted liver. The youngest recipients, particularly infants under one year who receive a living donor graft for conditions like biliary atresia, have some of the best projected outcomes of all: up to 93% survival at 30 years.
Life After Transplant
Survival statistics only tell part of the story. What matters equally to most recipients is how they feel and what they can do. In a study assessing quality of life among transplant recipients, 94% reported excellent overall quality of life, with high scores on standardized wellbeing measures. After a recovery period that varies from weeks to months depending on complications, most recipients are able to return to work, exercise, travel, and resume the daily activities that liver disease had taken away from them.
You will take immunosuppressive medications for the rest of your life to prevent rejection. These come with side effects, including increased susceptibility to infections and, over many years, a modestly higher risk of certain cancers. Regular blood tests and checkups are a permanent part of life after transplant. But for people who were seriously ill with liver failure or cancer, these tradeoffs represent a dramatic improvement. The trajectory from a five-year survival rate below 75% in the early transplant era to above 80% today reflects not just better surgery, but better long-term management of recipients who go on to live active, full lives.